Search

Your search keyword '"Antonucci G."' showing total 40 results

Search Constraints

Start Over You searched for: Author "Antonucci G." Remove constraint Author: "Antonucci G." Topic medicine.disease Remove constraint Topic: medicine.disease
40 results on '"Antonucci G."'

Search Results

1. Urgent Measures for the Containment of the Coronavirus (Covid-19) Epidemic in the Neurorehabilitation/Rehabilitation Departments in the Phase of Maximum Expansion of the Epidemic

2. Psychometric evaluation of an Italian adaptation of the PROMIS® anxiety short form in Immune-Mediated Inflammatory Diseases. An Item Response Theory analysis

Catalog

Books, media, physical & digital resources

3. Predictors of active cancer thromboembolic outcomes

4. Evolving treatment implementation among HIV- infected pregnant women and their partners: Results from a national surveillance study in Italy, 2001-2015

5. Clinical, epidemiological and virological features of acute hepatitis B in Italy

6. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry

7. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

8. Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study

9. Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors

10. Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study

11. Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C

12. Italian normative data for a stroke specific cognitive screening tool: the Oxford Cognitive Screen (OCS)

13. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

14. Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients

15. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort

16. Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting

17. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

18. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

19. Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe

20. Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patients

21. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

22. Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

23. Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

24. Patterns of chronic hepatitis B in Central Italy: a cross-sectional study

25. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

26. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?

27. Economic evaluation of HIV treatments: The I.CO.N.A. cohort study

28. Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy

29. Effect of Hepatitis C Virus Genotype on CD4+T Cell Count in a Cohort of Antiretroviral‐Naive HIV‐1–Infected Individuals

30. Incidence of Adipose Tissue Alterations in First-Line Antiretroviral Therapy

31. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals

32. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

33. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

34. Risk Factors and Outcome among a Large Patient Cohort with Community-Acquired Acute Hepatitis C in Italy

35. Self-reported hypertension, dyslipidemia and hyperuricemia management by Italian Internal Medicine Units: a national survey of the FADOI Study Group in Cardiovascular Medicine

36. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

37. Treatment options in HBV

38. HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin

39. Exploring the syndrome of spatial unilateral neglect through an illusion of length

40. Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy